The proportion of cancer deaths attributable to smoking differs among states, but the highest proportion was seen in the Southern United States.
Oncology
Advertisement
Top news of the day from across the health care landscape.
Advertisement
Total thyroidectomy is the most common treatment for thyroid cancer.
Ribociclib seeks approval as a first-line treatment of postmenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative advanced or metastatic breast cancer.
The FDA has accepted Novartis’ New Drug Application (NDA) and granted Priority Review for LEE011 (ribociclib).
A chemical inhibitor was found to limit the growth of lung tumor cells and may provide better treatment for lung cancer patients.
Advertisement
HIV positive patients coinfected with hepatitis may face elevated cancer risk.
Stay up-to-date with the hottest news in pharmacy!
Tumor markers can help guide future treatments for patients with bladder cancer.
Top news of the week in oncology and cancer drug development.
Advertisement
Developed countries may be able to assist developing countries in ensuring their drugs are safe.
Top news of the day from across the health care landscape.
Testing method could improve radioembolization technique in cancer treatment.
Newly-discovered compound blocks an essential protein in sustaining tumor growth.
Keytruda approved as a first-line treatment for non-small cell lung cancer.
Swedish study suggests that more American men can opt surveillance over prostate cancer treatment.
Astellaas Pharma has entered into an agreement to acquire Ganymed and its investigational cancer antibodies.
Triolimus contains paclitaxel plus 2 agents to prevent chemotherapy resistance.
Injections of nanoliposomes reversed memory loss associated with Alzheimer’s disease in mouse models.
Top news of the day from across the health care landscape.
Eli Lilly and Company will launch a revised version of a tool that tracks the progress of cancer over time.
A specific mark in histones speeds up repairs in cancer cells, increasing their resistance to treatment.
Top news of the day from across the health care landscape.
A novel approach looks to provide researchers with the tools to make accurate and safe predictions for cancer patients.
Ribociclib treats patients with HR+/HER2- advanced or metastatic breast cancer.
Experimental drug treats patients with HR+/HER2- advanced or metastatic breast cancer.
As symptoms of depression worsen, so too does the length of survival in lung cancer patients, according to a study published in the Journal of Clinical Oncology.
Fission yeast is a low cost and fast system that can improve the cancer drug discovery process.
Top news of the day from across the health care landscape.
A method to detect underwater structure damage could be used to detect breast cancer.
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5